quinfamide has been researched along with etofamide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bailey, DM; Carlson, JA; Mount, EM; Siggins, J; Slighter, RG; Yarinsky, A | 1 |
| Cedillo-Rivera, R; Muñoz, O; Tapia-Contreras, A; Torres, J | 1 |
| Nájera Ruano, S; Olaeta Elizalde, R; Pérez Huacuja, R | 1 |
1 trial(s) available for quinfamide and etofamide
| Article | Year |
|---|---|
[Comparison of quinfamide vs etofamide in the Mexican population with intestinal amebiasis].
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Amebicides; Child; Child, Preschool; Dysentery, Amebic; Humans; Infant; Mexico; Middle Aged; Quinolines | 1996 |
2 other study(ies) available for quinfamide and etofamide
| Article | Year |
|---|---|
1-(Dichloroacetyl)-1,2,3,4-tetrahydro-6-quinolinol esters. New potent antiamebic agents.
Topics: Amebicides; Animals; Cecum; Cricetinae; Dysentery, Amebic; Female; Hydroxyquinolines | 1979 |
In vitro susceptibility of Entamoeba histolytica to fluoroquinolones, nitrofurans and other antiamebic agents.
Topics: Acetamides; Amebicides; Animals; Anti-Infective Agents; Drug Evaluation, Preclinical; Entamoeba histolytica; Fluoroquinolones; Nitrofurans; Nitroimidazoles; Quinolines | 1997 |